Merck KGaA (OTCMKTS:MKKGY - Get Free Report) shares reached a new 52-week low on Wednesday . The stock traded as low as $28.82 and last traded at $28.88, with a volume of 139018 shares traded. The stock had previously closed at $29.22.
Analyst Ratings Changes
Separately, The Goldman Sachs Group started coverage on shares of Merck KGaA in a research note on Thursday, September 19th. They set a "buy" rating on the stock.
Read Our Latest Stock Analysis on Merck KGaA
Merck KGaA Stock Down 1.2 %
The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The company has a fifty day simple moving average of $31.74 and a 200-day simple moving average of $34.31. The firm has a market cap of $18.66 billion, a P/E ratio of 17.83, a price-to-earnings-growth ratio of 2.37 and a beta of 0.93.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.